| abstract |
Certain aspects of the current invention are directed to a reprogramming of somatic cells to provide therapeutic cells for treatment of diseases such as retinopathies. Certain aspects of the invention are directed to reprogramming compositions, as well as the use of such compositions, for reprogramming somatic cells, the compositions including five small molecules (5C) that can chemically induce conversion to other target cell types. |